Wednesday, July 13, 2022

Day 894: VAERS, What VAERS?

The management apologizes for our unintentional summer break here at PlagueBlog Headquarters. It was not due to ninja-COVID but to a mainframe breakdown; sadly the pandemic has in no way helped with the shortage of COBOL programmers and vacuum tubes.

We hope to report soon on case rates, the ongoing scourge of booster-driven OAS variants, jabbing defenseless infants with no scientific basis, and the vaccine-driven plunge in fertility in various countries that bother to publish their birth rates.

But the truly notable news of the past month came out of an FOIA request by Children's Health Defense, in which the CDC admits to never calculating their own standard adverse event statistic out of VAERS for the COVID vaccines. As usual, the bad cat said it best:
not only did they not perform the safety monitoring they were supposed to. at all. but they go on to claim that doing so is outside their purview and suggest asking the FDA instead. (who does not do this work, it’s supposed to be the CDC.)

this is just stunning.

what a complete and total fail and abrogation of duty and diligence.

either “most robust in US history” was a complete and total fabrication or wow have we been running around totally unprotected for decades. which one fills you with confidence?

[Some commentary and a screenshot of OpenVAERS data for the US omitted.]

quite literally any other vaccine in history would have been pulled off the market for 1/100th of this.

[...]

the agency whose specific purview and policy was to monitor this data just told you that everything was fine and their diligence the most robust in history while failing to do even the most rudimentary first pass work they were supposed to. they not only missed but misled about what is probably the single most severe safety signal in pharmaceutical history.

and then they said "not my job."
P.S. The state gave up the ghost on "daily" case reporting on July 8th, at which point cases were up a tenth of a percentage point.

No comments: